How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biological CP (Bio-Pesticide) Market
- By Product Type: Microbial Pesticides, Biochemical Pesticides, Plant-Incorporated Protectants (PIPs), Botanical Pesticides
- By Mode of Application: Seed Treatment, Foliar Spray, Soil Treatment, Post-Harvest Treatment
- By Target Pest Type: Insecticides, Fungicides, Herbicides, Nematicides
- By Formulation Type: Wettable Powder, Emulsifiable Concentrate, Granules, Suspension Concentrate
- By Crop Type: Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Turf & Ornamentals
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Microbial Pesticides leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Biological CP (Bio-Pesticide) Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Mode of Application 4
Target Pest Type 4
Formulation Type 4
Crop Type 4
Companies profiled
Bayer Crop Science
Syngenta AG
BASF SE
UPL Limited
Valent BioSciences Corporation
Certis USA LLC
Marrone Bio Innovations
Koppert Biological Systems
Andermatt Biocontrol AG
Biobest Group NV
Sumitomo Chemical Company
Limited
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer Crop Science
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →UPL Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Valent BioSciences Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Certis USA LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Marrone Bio Innovations
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Koppert Biological Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Andermatt Biocontrol AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Biobest Group NV
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Sumitomo Chemical Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Isagro S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Lallemand Plant Care
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →T. Stanes & Company Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →AgBiome
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$7,207M by 2033 · 3.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Microbial Pesticides50.7
- Biochemical Pesticides17.5
- Plant-Incorporated Protectants (PIPs)14.5
- Botanical Pesticides17.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,759M → $2,582M · 4.9%
Europe$1,226M → $1,613M · 3.5%
Asia Pacific$1,119M → $1,576M · 4.4%
Latin America$693.0M → $903.0M · 3.4%
Middle East and Africa$533.1M → $739.0M · 4.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.802026
3.812027
3.832028
3.832029
3.852030
3.852031
3.872032
3.882033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer Crop Science20.0
- Syngenta AG15.2
- BASF SE9.7
- UPL Limited9.8
- Valent BioSciences Corporation5.2
- Certis USA LLC12.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type16.9%
Mode of Application20.7%
Target Pest Type23.7%
Formulation Type22.1%
Crop Type16.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.8
- Europe21.8
- Asia Pacific21.3
- Latin America12.2
- Middle East and Africa10.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer Crop Science | 89 | 84 | 81 | 87 | 83 | 78 | 84 |
| Syngenta AG | 73 | 91 | 72 | 86 | 78 | 79 | 80 |
| BASF SE | 87 | 68 | 63 | 82 | 84 | 72 | 76 |
| UPL Limited | 67 | 72 | 63 | 82 | 78 | 66 | 71 |
| Valent BioSciences Corporation | 54 | 62 | 76 | 61 | 53 | 63 | 62 |
| Certis USA LLC | 54 | 50 | 62 | 49 | 57 | 53 | 54 |
| Marrone Bio Innovations | 61 | 49 | 50 | 55 | 55 | 55 | 54 |
| Koppert Biological Systems | 49 | 51 | 47 | 56 | 40 | 45 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer Crop Science
- Syngenta AG
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer Crop Science | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Syngenta AG | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| BASF SE | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| UPL Limited | ◐ | ◐ | − | ◐ | ✓ | ◐ |
| Valent BioSciences Corporation | ◐ | − | ◐ | − | ◐ | ◐ |
| Certis USA LLC | − | ◐ | ◐ | − | ◐ | ◐ |
| Marrone Bio Innovations | ◐ | − | − | − | − | ◐ |
| Koppert Biological Systems | ◐ | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer Crop Science84
2Syngenta AG80
3BASF SE76
4UPL Limited71
5Valent BioSciences Corporation62
6Certis USA LLC54
7Marrone Bio Innovations54
8Koppert Biological Systems48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bayer Crop ScienceSyngenta AG
Challenger2
Strong scale, closing on the leaders.
BASF SEUPL Limited
Contender1
Focused players with pockets of strength.
Valent BioSciences Corporation
Niche3
Specialists in a single segment or region.
Certis USA LLCMarrone Bio InnovationsKoppert Biological Systems
Go-to-market strategy
Land Product Type in North America, then scale across Biological CP (Bio-Pesticide) Market — a $540M beachhead inside a $8.56B market.
Beachhead (SOM)$540Mobtainable near-term
Serviceable (SAM)$3.43Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Microbial Pesticides
Best fit — highest urgency & budget in Product Type.
Economic buyer75 fit
Biochemical Pesticides
Strong fit — clear ROI and a fast path to value.
End user68 fit
Plant-Incorporated Protectants (PIPs)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mode of Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Pest Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biological CP (Bio-Pesticide) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation13%
Closed-won8%
$17.4KCAC
$101KLTV
5.8:1LTV : CAC
< 2 moCAC payback
Investment thesis
Biological CP (Bio-Pesticide) Market is a durable-growth opportunity — $806M by 2033, compounding at 8.5%.
TAM · 2025$421Mtoday
TAM · 2033$806Mforecast
CAGR8.5%2027–2033
Cumulative$5.36Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$806MTotal addressable market
SAM$294MServiceable available market
SOM$56MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$806MLarge & growingTAM by 2033 at 8.5% CAGR
$294MServiceable nowreachable with today’s model
$56MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$629MBear5.5% CAGR
$806MBase8.5% CAGR
$1.03BBull11.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mode of Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biological CP (Bio-Pesticide) Market — a $4.41B market by 2033. Plan: grow share from 9.7% to 17.0%.
Market size · 2033$4.41Btotal addressable
Market CAGR5.8%2027–2033
Target share17.0%from 9.7% today
Revenue ambition$749Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 17.0% | Ahead |
| Revenue | $402M | $749M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.4% | 40.4% | On track |
| Customer retention | 90.5% | 95.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mode of Application capability
A defensible second engine — invest in Mode of Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mode of Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $107M capacity & capability investment
- Greenlight bolt-on M&A in Mode of Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Sales deck · value proposition
Win the Biological CP (Bio-Pesticide) Market conversation — a $8.34B market you can size, segment and defend in minutes.
Market size · 2033$8.34Btotal opportunity
Growth8.4%CAGR to 2033
Addressable buyers1,380+accounts in scope
Typical ROI5.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.2×return on cost, year one
< 2 mopayback period
$84K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Bayer Crop ScienceSyngenta AGBASF SEUPL LimitedValent BioSciences CorporationCertis USA LLCMarrone Bio InnovationsKoppert Biological Systems+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biological CP (Bio-Pesticide) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biological CP (Bio-Pesticide) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biological Derived Devices Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBiological Detection Equipment Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportBiological Digital Microscopes Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportBiological Disinfectant Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBiological Drug Api Manufacturing Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBiological Drug Detector Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBiological Engineering Equipment Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBiological Fermentation System Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBiological Fermentation Tank Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBiological Fertilizer Fungicide Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiological Glue Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBiological Heart Valve Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.